Sei Investments Co. Sells 116,008 Shares of Ardent Health, Inc. $ARDT

Posted by Francis Steltz on Aug 17th, 2026

Sei Investments Co. lessened its holdings in shares of Ardent Health, Inc. (NYSE:ARDT – Free Report) by 74.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,976 shares of the company’s stock after selling 116,008 shares during the quarter. Sei Investments Co.’s holdings in Ardent Health were worth $342,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. Geode Capital Management LLC increased its stake in shares of Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after purchasing an additional 1,769 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in Ardent Health by 8.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock worth $376,000 after purchasing an additional 2,110 shares during the period. Caitong International Asset Management Co. Ltd lifted its position in Ardent Health by 1,177.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after purchasing an additional 2,638 shares in the last quarter. Alliancebernstein L.P. lifted its position in Ardent Health by 24.8% during the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock valued at $218,000 after purchasing an additional 3,272 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares in the last quarter.

Insider Activity

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average cost of $8.81 per share, with a total value of $88,100.00. Following the acquisition, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at approximately $2,900,102.23. The trade was a 3.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.90% of the stock is owned by company insiders.

Ardent Health Trading Up 0.2%

Shares of ARDT stock opened at $10.93 on Monday. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 3.13 and a beta of 0.70. Ardent Health, Inc. has a 12-month low of $7.71 and a 12-month high of $15.48. The stock’s 50-day moving average price is $10.21 and its 200-day moving average price is $9.59.

Ardent Health (NYSE:ARDT – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities research analysts predict that Ardent Health, Inc. will post 0.95 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on the company. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th. Truist Financial boosted their price objective on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Zacks Research lowered shares of Ardent Health from a “hold” rating to a “strong sell” rating in a report on Thursday, August 6th. Finally, Weiss Ratings lowered shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Ardent Health currently has a consensus rating of “Hold” and a consensus price target of $13.05.

View Our Latest Analysis on ARDT

Ardent Health Profile

(Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.